Your browser doesn't support javascript.
loading
Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity.
Huyghe, A; Furlan, G; Schroeder, J; Cascales, E; Trajkova, A; Ruel, M; Stüder, F; Larcombe, M; Yang Sun, Y Bo; Mugnier, F; De Matteo, L; Baygin, A; Wang, J; Yu, Y; Rama, N; Gibert, B; Kielbassa, J; Tonon, L; Wajda, P; Gadot, N; Brevet, M; Siouda, M; Mulligan, P; Dante, R; Liu, P; Gronemeyer, H; Mendoza-Parra, M; Polo, J M; Lavial, F.
Afiliação
  • Huyghe A; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France. aurelia.huyghe@lyon.
  • Furlan G; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Schroeder J; Lunenfeld-Tanenbaum Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Cascales E; Department of Anatomy and Developmental Biology, Monash University, Melbourne, Clayton, Australia.
  • Trajkova A; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Ruel M; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Stüder F; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Larcombe M; Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Université d'Évry, Université Paris-Saclay, Évry, France.
  • Yang Sun YB; Department of Anatomy and Developmental Biology, Monash University, Melbourne, Clayton, Australia.
  • Mugnier F; Department of Anatomy and Developmental Biology, Monash University, Melbourne, Clayton, Australia.
  • De Matteo L; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Baygin A; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Wang J; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Yu Y; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Rama N; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Gibert B; Apoptosis, Cancer and Development Laboratory, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Kielbassa J; Apoptosis, Cancer and Development Laboratory, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Tonon L; Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Wajda P; Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Gadot N; Cellular Reprogramming, Stem Cells and Oncogenesis Laboratory, Equipe Labellisée la Ligue Contre le Cancer, LabEx Dev2Can, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Brevet M; Research Pathology Platform, Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Siouda M; Department of Pathology, HCL Cancer Institute and Université Claude Bernard Lyon 1, Lyon, France.
  • Mulligan P; Epigenetics and cancer Laboratory - Lyon University, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Dante R; Epigenetics and cancer Laboratory - Lyon University, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Liu P; Institut NeuroMyoGene, Division PGNM, Universite Claude Bernard Lyon 1, Universite de Lyon, INSERM U1315, CNRS UMR5261, Lyon, France.
  • Gronemeyer H; Apoptosis, Cancer and Development Laboratory, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Mendoza-Parra M; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Polo JM; Institut de génétique et de biologie moléculaire et Cellulaire, CNRS UMR 7104 INSERM, Strasbourg, France.
  • Lavial F; Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Université d'Évry, Université Paris-Saclay, Évry, France.
Nat Cell Biol ; 24(9): 1350-1363, 2022 09.
Article em En | MEDLINE | ID: mdl-36075976
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reprogramação Celular / Células-Tronco Pluripotentes Induzidas Tipo de estudo: Prognostic_studies Idioma: En Revista: Nat Cell Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reprogramação Celular / Células-Tronco Pluripotentes Induzidas Tipo de estudo: Prognostic_studies Idioma: En Revista: Nat Cell Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França